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Résumé en
anglais
Magnesium (Mg) status has recently drawn close attention in chronic kidney
disease and in kidney transplant recipients. This review aims to evaluate the body
of evidence linking hypomagnesemia to clinical consequences in these specific
populations. After a brief summary of the main mechanisms involved in Mg
regulation and of Mg status in end-stage renal disease, the review focuses on the
relationship between hypomagnesemia and cardiovascular risk in kidney transplant
recipients. A body of evidence in recent studies points to a negative impact of
hypomagnesemia on post-transplant diabetes mellitus (PTDM) and cardiovascular
risk, which currently represent the main threat for morbidity and mortality in
kidney transplantation. Deleterious biological mechanisms induced by
hypomagnesemia are also discussed. While data analysis enables us to conclude
that hypomagnesemia is linked to the development of PTDM, studies prospectively
evaluating the impact of hypomagnesemia correction after kidney transplantation


































Publié sur Okina (http://okina.univ-angers.fr)
